Moderna has secured approval from Health Canada for Spikevax, its updated Covid-19 mRNA vaccine, which targets the SARS-CoV-2 ...

All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone CAMBRIDGE, MA / ACCESS ...

CAMBRIDGE, MA / ACCESS Newswire / August 21, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced its participation in the ...

Investing.com -- Moderna Inc (NASDAQ:MRNA) stock fell 5.5% and Pfizer Inc (NYSE:PFE) shares dropped 2.6% following reports from Newsweek and The Daily Beast that the Trump administration may be ...

Moderna announced on Friday that its updated COVID-19 mRNA vaccine, Spikevax, has received authorization in Canada for those ...

The approval keeps Moderna on track to deliver doses ahead of the 2025-2026 vaccination season. Production will take place in ...

All pre-filled syringe doses for the Canadian market will be manufactured domestically for the first time, with drug ...

Biotech giant Moderna announced it will lay off 10% of its workforce in a move CEO Stéphane Bancel called “a difficult decision but necessary step forward,” in an internal memo sent to employees on ...

Perhaps the most critical aspect of Moderna's business to pay attention to right now is its late-stage pipeline. The company ...

The biotech company said Friday the latest version of its Covid-19 mRNA vaccine, Spikevax, has been authorized by Health Canada. And for the first time, all pre-filled syringe doses of the vaccine ...

To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Moderna said Thursday it plans to lay off 10% of its workforce, or more than 800 employees, as part of an ...

Oncologists and scientists warn that extensive cuts to mRNA funding will have devastating impacts on cancer vaccine ...